Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Merck
Mallinckrodt
Baxter
Boehringer Ingelheim

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

CLOFARABINE Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Clofarabine, and when can generic versions of Clofarabine launch?

Clofarabine is a drug marketed by Abon Pharms Llc, Accord Hlthcare, Amneal Pharms Co, Dr Reddys Labs Ltd, Gland Pharma Ltd, Hospira Inc, Ingenus Pharms Llc, Msn Labs Pvt Ltd, and Mylan Labs Ltd. and is included in nine NDAs.

The generic ingredient in CLOFARABINE is clofarabine. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the clofarabine profile page.

Drug patent expirations by year for CLOFARABINE
Drug Prices for CLOFARABINE

See drug prices for CLOFARABINE

Recent Clinical Trials for CLOFARABINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Milton S. Hershey Medical CenterPhase 2
Mesoblast, Inc.Phase 2
Incyte CorporationPhase 2/Phase 3

See all CLOFARABINE clinical trials

Recent Litigation for CLOFARABINE

Identify potential future generic entrants

District Court Litigation
Case NameDate
GENZYME CORPORATION v. HERITAGE PHARMA LABS, INC.2014-09-24
SOUTHERN RESEARCH INSTITUTE v. ABON PHARMACEUTICALS LLC2012-07-27

See all CLOFARABINE litigation

Synonyms for CLOFARABINE
(2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
(2R,3R,4S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol
(2R,3R,4S,5R)-5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol
(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
(2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine
123318-82-1
2-Chloro-9-(2-deoxy-2-fluoro-?-D-arabinofuranosyl)-9H-purin-6-amine
2-Chloro-9-(2-Deoxy-2-Fluoro-B -D-Arabinofuranosyl)-9h-Purin-6-Amine
2-Chloro-9-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-9H-purin-6-amine
2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine
2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-adenine
2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)adenine
2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)adenine
2-Cl-2'-F-araA
318C821
3S211048
5-(6-amino-2-chloro-purin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol
762RDY0Y2H
9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-
9H-Purine-6-amine,2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-
AB00430247_06
AB00430247-03
AB00430247-04
AC-274
AC1L3OC8
ACT05522
AKOS005063562
AKOS015919355
AN-15999
API0002064
AS-12958
BC222364
BCP0726000280
BCP23422
BCP9000540
BIFK0045
C-18934
C1-F-Ara-A
C10H11ClFN5O3
CAFdA
CAS-123318-82-1
CC-25917
CFB
CHEBI:681569
CHEMBL1750
Cl-F-Ara-A
Cl-F-araA
Clofarabin
clofarabina
Clofarabine (JAN/USAN/INN)
Clofarabine [USAN:INN:BAN]
Clofarabine [USAN]
Clofarabine, >=98% (HPLC)
Clofarabine,Clolar, Evoltra
clofarabinum
Clofarex
Clolar
Clolar (TN)
CS-0373
D03546
DB00631
DSSTox_CID_26437
DSSTox_GSID_46437
DSSTox_RID_81613
DTXSID5046437
Evoltra
FT-0082882
FT-0601617
GTPL6802
HMS2090A07
HY-A0005
KB-49091
KS-00000650
LS-126466
MCULE-2276059681
MFCD00871077
MLS003915615
MolPort-005-941-711
NCGC00164553-01
NCGC00164553-02
PubChem19116
s1218
SAR-393590
SB17339
SC-22779
SCHEMBL9040
SMR002530055
SR-01000930565
SR-01000930565-3
ST24046359
SW218080-2
Tox21_112182
Tox21_112182_1
UNII-762RDY0Y2H
W-5182
WDDPHFBMKLOVOX-AYQXTPAHSA-N
Z1557400138
ZINC3798247

US Patents and Regulatory Information for CLOFARABINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abon Pharms Llc CLOFARABINE clofarabine SOLUTION;INTRAVENOUS 204029-001 May 9, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Ingenus Pharms Llc CLOFARABINE clofarabine SOLUTION;INTRAVENOUS 210270-001 Sep 14, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd CLOFARABINE clofarabine SOLUTION;INTRAVENOUS 205375-001 Nov 6, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Msn Labs Pvt Ltd CLOFARABINE clofarabine SOLUTION;INTRAVENOUS 209775-001 Dec 6, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Accord Hlthcare CLOFARABINE clofarabine SOLUTION;INTRAVENOUS 212034-001 Feb 22, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms Co CLOFARABINE clofarabine SOLUTION;INTRAVENOUS 208857-001 Nov 6, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira Inc CLOFARABINE clofarabine SOLUTION;INTRAVENOUS 210283-001 Dec 27, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Baxter
Mallinckrodt
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.